(Q43868207)

English

Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

author name string

Conlin PR

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Gerth WC

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Fox J

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Roehm JB

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Boccuzzi SJ

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1999-2010

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuation of initial antihypertensive medication after 1 year of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The dropout problem in antihypertensive treatment. A pilot study of social and emotional factors influencing a patient's ability to follow antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predictive of attendance at clinic and blood pressure control in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of patient compliance in the treatment of hypertension. Report of the NHLBI Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of the noncompliant hypertensive patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The costs of interrupting antihypertensive drug therapy in a Medicaid population.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefits of adherence to anti-hypertensive drug therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of prescription and medical records in reflecting patient antihypertensive drug therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Using healthcare claims data for outcomes research and pharmacoeconomic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug coverage and drug purchases by Medicare beneficiaries with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(01)80152-1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

release_vxggzxgnlzh2lhtfbxtgzevtvm

1 reference

https://api.fatcat.wiki/v0/release/vxggzxgnlzh2lhtfbxtgzevtvm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43868207&oldid=2104037113"